ddp4 inhibitors and glp 1 GLP-1 receptor agonists DPP-4 Pathway, Pharmacodynamics DPP-4 inhibitors in the treatment

2-chloro-10-(3-(4-methylpiperazin-1-yl)propyl)-10h-phenothiazine Dimaleate 41

J Pharmacol Exp Ther 325(1):175182

Periodic maintenance infusionstypically recommended every one to two months following the initial coursehelp sustain the systemic antioxidant levels achieved during treatment, supporting continued melanin modulation and oxidative stress reduction

It can block the stereotypy from amphetamine and other narcoleptics

Data on one do not automatically transfer to the other

Clinical studies show correct injection technique reduces local tissue reactions and improves medication absorption, directly affecting treatment outcomes